Get Our FREE Newsletter

Sign Up

Biotech Stock Roundup: BIIB's Drug Approval, ALXN Drug Label Expansion & More

Lorem ipsum dolor sit amet,sed diam nonumy eirmod tempor invidunt ut labore

Lorem ipsum dolor sit amet,sed diam nonumy eirmod tempor invidunt ut labore

Spread the love

The biotech sector continues to be in focus with regular pipeline and regulatory updates. Drug approvals were in focus last week.

This post was originally published on this site